Antimalarial Drugs Market Size, Share, Growth Analysis, By drug class(Global antimalarial drugs industry share from the aryl aminoalcohol compounds segment might grow at a considerable pace by 2032. The number of people suffering from malaria across the world is increasing every year. About 241 million malaria cases were registered across the globe in 2022, with the WHO Africa region continuing to account for a large share of the disease burden. This will encourage people to take antimalarial drugs to prevent the disease infection. With regards to route of administration, antimalarial drugs market value from the oral segment is expected to increase at a significant rate by 2032. There are many advantages associated with this route of administration, such as better patient compliance), By application(The treatment segment is expected to capture a sizeable share of antimalarial drugs market by 2032. Malaria treatments depend on many factors including the species of malaria parasite, intensity of the disease, and the country/region in which the patient contracted the infection. Increasing global mortality rate from malaria might require people to receive proper medication to treat the disease effectively, thereby propelling the market growth.) - Industry Forecast 2024-2031

Segmentation Analysis:

The Antimalarial Drugs Market is segmented by drug class, application. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.

• Based on drug class the market is segmented as, Global antimalarial drugs industry share from the aryl aminoalcohol compounds segment might grow at a considerable pace by 2032. The number of people suffering from malaria across the world is increasing every year. About 241 million malaria cases were registered across the globe in 2022, with the WHO Africa region continuing to account for a large share of the disease burden. This will encourage people to take antimalarial drugs to prevent the disease infection. With regards to route of administration, antimalarial drugs market value from the oral segment is expected to increase at a significant rate by 2032. There are many advantages associated with this route of administration, such as better patient compliance, safety, easy ingestion, pain avoidance, and great versatility in accommodating different types of medicines. Also, since hydroxychloroquine comes only in tablet form, more patients will opt for oral administration throughout the forecast timeframe., Based on malaria type, Antimalarial drugs industry revenue from the Plasmodium falciparum segment is predicted to increase steadily by 2032. There is a large population pool that is heavily exposed to mosquito bites, which raises their risk of getting infected by Plasmodium falciparum. People with low immune response and their lack of access to primary healthcare facilities are some of the factors driving the segmental growth during the forecast period.
• Based on application the market is segmented as, The treatment segment is expected to capture a sizeable share of antimalarial drugs market by 2032. Malaria treatments depend on many factors including the species of malaria parasite, intensity of the disease, and the country/region in which the patient contracted the infection. Increasing global mortality rate from malaria might require people to receive proper medication to treat the disease effectively, thereby propelling the market growth., Based on distribution channel, Antimalarial drugs market size from hospital pharmacies is estimated to witness a substantial CAGR through 2032. These pharmacies provide care teams with the opportunity to come together to improve patient outcomes. They also avoid errors while prescribing medications, which often occur when patients switch between retail pharmacies after discharge. These benefits will encourage patients to buy medicines from hospital pharmacies. U.S. antimalarial drugs market share is anticipated to showcase appreciable growth over the analysis timeframe. The country is witnessing a strong rise in the number of people falling prey to malaria. According to the U.S. Centers for Disease Control and Prevention (CDC), the U.S. records around 2,000 cases of malaria each year. The rising import of hydroxychloroquine tablets in the country will also contribute to the development of antimalarial drugs industry.